We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+9.94%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.86B
AUM Growth
+$282M
Cap. Flow
-$20.7M
Cap. Flow %
-0.43%
Top 10 Hldgs %
7.44%
Holding
788
New
106
Increased
196
Reduced
396
Closed
66

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$25.2M
2
AAPL icon
Apple
AAPL
+$23.6M
3
NVDA icon
NVIDIA
NVDA
+$17.6M
4
FN icon
Fabrinet
FN
+$16.6M
5
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$16.4M

Sector Composition

Rank Sector Weight
1 Industrials 20.51%
2 Financials 18.46%
3 Healthcare 14.53%
4 Technology 13.2%
5 Consumer Discretionary 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWP icon
676
Perella Weinberg Partners
PWP
$1.3B
$230K ﹤0.01%
16,310
+582
+4% +$7.31K
SYNA icon
677
Synaptics
SYNA
$4.19B
$230K ﹤0.01%
2,356
-46,687
-95% -$4.91M
BOOT icon
678
Boot Barn
BOOT
$5.14B
$230K ﹤0.01%
+2,412
New +$199K
CYTK icon
679
Cytokinetics
CYTK
$10.8B
$224K ﹤0.01%
+3,192
New +$247K
SWTX
680
DELISTED
SpringWorks Therapeutics
SWTX
$223K ﹤0.01%
4,530
-25,475
-85% -$1.18M
BPMC
681
DELISTED
Blueprint Medicines
BPMC
$220K ﹤0.01%
+2,320
New +$199K
SNCY
682
DELISTED
Sun Country Airlines
SNCY
$216K ﹤0.01%
14,315
-174,059
-92% -$2.51M
FERG icon
683
Ferguson
FERG
$50.5B
$216K ﹤0.01%
+987
New +$197K
APGE icon
684
Apogee Therapeutics
APGE
$10.2B
$212K ﹤0.01%
+3,188
New +$139K
EBMT icon
685
Eagle Bancorp Montana
EBMT
$188M
$209K ﹤0.01%
16,239
-3,578
-18% -$49.3K
VLO icon
686
Valero Energy
VLO
$91.3B
$206K ﹤0.01%
+1,208
New +$173K
SNA icon
687
Snap-on
SNA
$21.4B
$203K ﹤0.01%
+685
New +$194K
SWKS icon
688
Skyworks Solutions
SWKS
$10.4B
$201K ﹤0.01%
1,857
-90,131
-98% -$9.45M
ZNTL icon
689
Zentalis Pharmaceuticals
ZNTL
$298M
$189K ﹤0.01%
+11,978
New +$165K
SPWH icon
690
Sportsman's Warehouse
SPWH
$46.8M
$187K ﹤0.01%
+60,059
New +$224K
FHN icon
691
First Horizon
FHN
$12B
$179K ﹤0.01%
11,609
+35
+0.3% +$502
STRO icon
692
Sutro Biopharma
STRO
$425M
$175K ﹤0.01%
3,095
+110
+4% +$4.86K
XRN
693
Chiron Real Estate Inc
XRN
$480M
$158K ﹤0.01%
3,620
+128
+4% +$6.14K
KRON
694
DELISTED
Kronos Bio
KRON
$150K ﹤0.01%
115,061
+6,832
+6% +$7.79K
CMPS
695
Compass Pathways
CMPS
$1.83B
$139K ﹤0.01%
+16,740
New +$169K
DOUG icon
696
Douglas Elliman
DOUG
$167M
$129K ﹤0.01%
81,452
-6,231
-7% -$12.8K
PRLD icon
697
Prelude Therapeutics
PRLD
$386M
$119K ﹤0.01%
+25,035
New +$97.4K
BCAB icon
698
BioAtla
BCAB
$5.91M
$108K ﹤0.01%
628
+38
+6% +$4.72K
TERN
699
DELISTED
Terns Pharmaceuticals
TERN
$101K ﹤0.01%
+15,466
New +$101K
MGTX icon
700
MeiraGTx Holdings
MGTX
$1.22B
$99.9K ﹤0.01%
+16,457
New +$104K

Similar funds

Kennedy Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Kennedy Capital Management held 788 positions worth $4.86B, up 6.2% from $4.58B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Kennedy Capital Management's Q1 2024 filing shows 106 new, 196 increased, 396 reduced and 66 closed positions. Its largest new stake was Fabrinet: 82,729 shares worth $15.6M. The largest sale was Axonics, Inc. Common Stock, an estimated $24.4M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kennedy Capital Management's largest Q1 2024 buy was Fabrinet: 82,729 shares worth $15.6M.
  • Kennedy Capital Management added most to Microsoft in Q1 2024, an estimated $25.2M increase.
  • Kennedy Capital Management's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $24.4M.
  • Kennedy Capital Management fully exited American Equity Investment Life Holding Company in Q1 2024, selling an estimated $10.3M.
  • Kennedy Capital Management's ten largest holdings make up 7.4% of its $4.86B portfolio in Q1 2024.
  • Kennedy Capital Management opened 106 new positions and closed 66 in Q1 2024.
  • Kennedy Capital Management's portfolio value rose 6.2% quarter-over-quarter to $4.86B.

Based on Kennedy Capital Management's 13F filing for Q1 2024, filed 15 May 2024.